Attached files
| file | filename |
|---|---|
| 8-K - 8-K - UroGen Pharma Ltd. | d942504d8k.htm |
| EX-10.1 - EX-10.1 - UroGen Pharma Ltd. | d942504dex101.htm |
Exhibit 16.1
June 9, 2020
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by UroGen Pharma Ltd. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Form 8-K of UroGen Pharma Ltd. dated June 8, 2020. We agree with the statements concerning our Firm contained therein.
Very truly yours,
/s/ Kesselman & Kesselman
Certified Public Accountants (Isr.)
A member firm of PricewaterhouseCoopers International Limited.
| Kesselman & Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 6812508, Israel, |
| P.O Box 50005 Tel-Aviv 6150001 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il |